Autori: Bila Jelena S
Naslov | Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group (Article) |
Autori | Fotiou Despina ... Bila Jelena S ![]() ![]() ![]() |
Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2025), vol. 25 br. 5, str. e310-e318 |
Projekat | Sanofi |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG) (Article) |
Autori | Kastritis Efstathios ... ![]() ![]() ![]() |
Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2025), vol. 25 br. 2, str. E71-E81 |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges (Review) |
Autori | Kozarac Sofija Ivanovic Jelena Mitrovic Marko Tomic-Vujovic Kristina ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | FRONTIERS IN PHARMACOLOGY, (2025), vol. 15 br. , str. - |
Projekat | Ministry of Science, Technological Development and Innovation [451-03-65/2024-03/200110] |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Risk Factors for Venous Thromboembolism in Acute Promyelocytic Leukemia (Article) |
Autori | Sabljic Nikica ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | CANCERS, (2024), vol. 16 br. 24, str. - |
Projekat | Ministry of Science, Technological Development and Innovation of the Republic of Serbia; [451-03-65/2004-03/200110] |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Does Double Mean Trouble? Coexistence of Myeloproliferative and Lymphoproliferative Neoplasms (Article) |
Autori | Lekovic Danijela R ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | JOURNAL OF CLINICAL MEDICINE, (2024), vol. 13 br. 6, str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study (Article) |
Autori | Pour Ludek ... Bila Jelena S ![]() |
Info | HAEMATOLOGICA, (2024), vol. 109 br. 3, str. 895-905 |
Projekat | [NCT04649060] |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3trial (Article) |
Autori | Dimopoulos Meletios Athanasios ... Bila Jelena S ![]() |
Info | LANCET HAEMATOLOGY, (2023), vol. 10 br. 10, str. E813-E824 |
Projekat | European Myeloma Network; Janssen Research Development |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network (Review) |
Autori | Ludwig Heinz ... Bila Jelena S ![]() |
Info | LANCET ONCOLOGY, (2023), vol. 24 br. 6, str. E255-E269 |
Projekat | Austrian Forum Against Cancer |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis - case report and literature review (Review) |
Autori | Jovicevic Vanja Bila Jelena S ![]() ![]() ![]() |
Info | SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, (2022), vol. 150 br. 5-6, str. 354-356 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone +/- subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial (Article) |
Autori | Terpos Evangelos ... Bila Jelena S ![]() |
Info | AMERICAN JOURNAL OF HEMATOLOGY, (2022), vol. 97 br. 4, str. 481-490 |
Projekat | European Myeloma Network (EMN); Janssen Research & Development, LLC; Janssen Global Services, LLC |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|